GERN FY 2017 Earnings — Geron Corporation Revenue & Financial Results | Market Cap Arena

GERNGeron Corporation

$1B

FY 2017 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$1M-82.7% YoY

Gross Profit

-$7M-692.2% margin

Operating Income

-$29M-2746.9% margin

Net Income

-$28M-2621.2% margin

EPS (Diluted)

$-0.18

Cash Flow

Operating Cash Flow

-$21M

Free Cash Flow

-$21M

Stock-Based Comp.

$8M

Balance Sheet

Total Assets

$110M

Total Liabilities

$7M

Stockholders' Equity

$104M

Cash & Equivalents

$17M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1M	$6M	-82.7%
Gross Profit	-$7M	-$9M	+13.6%
Operating Income	-$29M	-$31M	+4.5%
Net Income	-$28M	-$30M	+5.5%